Aligos Therapeutics to present hep B data at AASLD Liver Meeting
Aligos Therapeutics will present clinical data for pevifoscorvir sodium in chronic hepatitis B, showing immune effects and viral suppression, at AASLD's The Liver Meeting 2026. Updates also cover ALG-170675 for hepatitis B and preclinical ALG-215007 for hepatitis delta virus.